Publications | Aron

Publications

All our publications

Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study

Fiala O

et al. Clin Exp Metastasis

2025

Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Rizzo M

et al. Cancer Med

2025

Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab

Incorvaia L,

et al. Sci Rep.

2025

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Santoni M

et al. Clin Genitourin Cancer

2023

First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study

Roviello

Roviello et al. Cancer Immunol Immunother

2025

Impact of time-of-day administration of immunotherapy on survival in metastatic renal cellcarcinoma: the MOUSEION-09 meta-analysis

Alessandro Rizzo

et al. Clin Exp Metastasis

2024

Do you want to join us ?

Coordinated and designed by Atteggiamento Digitale .

Legal and Privacy.